Photocure: Partner announces First Patient Procedure with Hexvix in China under Special Access Program
Press release – Oslo, Norway, December 27, 2021: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner and exclusive distributor, Asieris MediTech in mainland China and Taiwan has communicated the first patient experience with Hexvix[®] in the Bo’ao Lecheng International Medical Tourism Pilot Zone in Hainan Province. Asieris communicated that Hexvix received its first prescription in China by Hainan General Hospital and the first patient procedure was completed on December 26.With this pilot program Asieris intends to gain further experience and build networks, in